Literature DB >> 22926210

Tuberculosis in children exposed at home to multidrug-resistant tuberculosis.

Mercedes C Becerra1, Molly F Franke, Sasha C Appleton, J Keith Joseph, Jaime Bayona, Sidney S Atwood, Carole D Mitnick.   

Abstract

BACKGROUND: The tuberculosis burden in children exposed at home to multidrug-resistant tuberculosis (MDR-TB) is unquantified. With limited access to MDR-TB treatment, likely millions of children share the experience of chronic exposure to an infectious patient.
METHODS: We conducted a retrospective cohort study of child and adult household contacts of patients treated for MDR-TB in Lima, Peru, in 1996 to 2003. The primary outcome was TB disease. We estimated prevalence of TB disease when the index case began MDR-TB treatment and incidence of TB disease over the subsequent 4 years.
RESULTS: Among 1299 child contacts, 67 were treated for TB. TB prevalence was 1771 (confidence interval [CI]: 1052-2489) per 100,000 children. In 4362 child-years of follow-up, TB incidence rates per 100,000 child-years were: 2079 (CI: 1302-2855) in year 1; 315 (CI: 6-624) in year 2; 634 (CI: 195-1072) in year 3; and 530 (CI: 66-994) in year 4. TB disease rates in children aged >1 year were not significantly different from those observed in adults. Children accounted for 20% of TB cases. Seven (87.5%) of 8 children tested had MDR-TB. Child contacts had TB disease rates approximately 30 times higher than children in the general population.
CONCLUSIONS: Children were at high risk for TB disease when the index case started MDR-TB treatment and during the following year. These results highlight the need for implementing contact investigations and establishing systems for prompt referral and treatment of pediatric household contacts of MDR-TB patients, regardless of the age of the child.

Entities:  

Mesh:

Year:  2013        PMID: 22926210     DOI: 10.1097/INF.0b013e31826f6063

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  11 in total

1.  Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease.

Authors:  Amita Gupta; Susan Swindells; Soyeon Kim; Michael D Hughes; Linda Naini; Xingye Wu; Rodney Dawson; Vidya Mave; Jorge Sanchez; Alberto Mendoza; Pedro Gonzales; Nagalingeswaran Kumarasamy; Kyla Comins; Francesca Conradie; Justin Shenje; Sandy Nerette Fontain; Anthony Garcia-Prats; Aida Asmelash; Supalert Nedsuwan; Lerato Mohapi; Umesh G Lalloo; Ana Cristina Garcia Ferreira; Christopher Mugah; Mark Harrington; Lynne Jones; Samyra R Cox; Betsy Smith; N Sarita Shah; Anneke C Hesseling; Gavin Churchyard
Journal:  Clin Infect Dis       Date:  2020-01-16       Impact factor: 9.079

Review 2.  Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis.

Authors:  Kwonjune J Seung; Salmaan Keshavjee; Michael L Rich
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-27       Impact factor: 6.915

Review 3.  Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis.

Authors:  N Sarita Shah; Courtney M Yuen; Moonseong Heo; Arielle W Tolman; Mercedes C Becerra
Journal:  Clin Infect Dis       Date:  2013-09-24       Impact factor: 9.079

4.  Commentary: a targets framework: dismantling the invisibility trap for children with drug-resistant tuberculosis.

Authors:  Mercedes C Becerra; Soumya Swaminathan
Journal:  J Public Health Policy       Date:  2014-09-11       Impact factor: 2.222

5.  Identification of Risk Factors of Multidrug-Resistant Tuberculosis by using Classification Tree Method.

Authors:  Dixin Tan; Bin Wang; Xuhui Li; Xiaonan Cai; Dandan Zhang; Mengyu Li; Cong Tang; Yaqiong Yan; Songlin Yu; Qian Chu; Yihua Xu
Journal:  Am J Trop Med Hyg       Date:  2017-09-21       Impact factor: 2.345

Review 6.  Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.

Authors:  Suzanne M Marks; Sundari R Mase; Sapna Bamrah Morris
Journal:  Clin Infect Dis       Date:  2017-06-15       Impact factor: 9.079

7.  High prevalence of infection and low incidence of disease in child contacts of patients with drug-resistant tuberculosis: a prospective cohort study.

Authors:  Helena Huerga; Elisabeth Sanchez-Padilla; Nara Melikyan; Hakob Atshemyan; Armen Hayrapetyan; Ani Ulumyan; Mathieu Bastard; Naira Khachatryan; Catherine Hewison; Francis Varaine; Maryline Bonnet
Journal:  Arch Dis Child       Date:  2018-12-06       Impact factor: 3.791

Review 8.  How to manage children who have come into contact with patients affected by tuberculosis.

Authors:  Laura Lancella; Andrea Lo Vecchio; Elena Chiappini; Marina Tadolini; Daniela Cirillo; Enrico Tortoli; Maurizio de Martino; Alfredo Guarino; Nicola Principi; Alberto Villani; Susanna Esposito; Luisa Galli
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2015-08-08

9.  Outcomes of Community-Based Systematic Screening of Household Contacts of Patients with Multidrug-Resistant Tuberculosis in Myanmar.

Authors:  Nang Thu Thu Kyaw; Aung Sithu; Srinath Satyanarayana; Ajay M V Kumar; Saw Thein; Aye Myat Thi; Pyae Phyo Wai; Yan Naing Lin; Khine Wut Yee Kyaw; Moe Myint Theingi Tun; Myo Minn Oo; Si Thu Aung; Anthony D Harries
Journal:  Trop Med Infect Dis       Date:  2019-12-25

Review 10.  Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.

Authors:  Carole D Mitnick; Carly A Rodriguez; Marita L Hatton; Grania Brigden; Frank Cobelens; Martin P Grobusch; Robert Horsburgh; Christoph Lange; Christian Lienhardt; Eyal Oren; Laura J Podewils; Barbara Seaworth; Susan van den Hof; Charles L Daley; Agnes C Gebhard; Fraser Wares
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.